First, Nox2 deficiency reduces myocardial oxidative stress, attenuates decreased catecholaminergic histofluorescence profiles, and restores protein expression levels of PGP9.5, GAP43, tyrosine hydroxylase and NET in doxorubicin-induced heart failure. This evidence concerns the gene SLC6A2 and heart failure.